Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Refsum

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Acta Pharmacologica Et Toxicologica|February 1, 1982
The mode of antiarrhythmic action of melperoneE S Platou, H Refsum, E S Myhre, et al.
QJM : Monthly Journal of the Association of Physicians|April 15, 2006
Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine StudyE Nurk, G S Tell, H Refsum, et al.
Biochemical Society Transactions|February 1, 1997
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteineE A Lien, G Anker, P E Lønning, et al.
Cardiovascular Research|November 1, 1990
Positive inotropy linked with class III antiarrhythmic action: electrophysiological effects of the cardiotonic agent DPI 201-106 in the dog heart in vivoE Mortensen, P M Tande, N E Kløw, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1997
Cardiovascular safety of MnDPDP and MnCl2P Jynge, H Brurok, A Asplund, et al.
Clinical Chemistry|September 11, 1998
Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapyA B Guttormsen, P M Ueland, P E Lønning, et al.
Clinical Chemistry|February 4, 1999
Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategiesG Hølleland, J Schneede, P M Ueland, et al.
European Journal of Clinical Nutrition|October 11, 2001
Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered?G T Bondevik, J Schneede, H Refsum, et al.
Circulation|May 31, 2001
Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action ProjectL El-Khairy, P M Ueland, H Refsum, et al.
International Journal of Cancer|April 22, 1993
Proliferation, migration and invasion of human glioma cells exposed to antifolate drugsA J Terzis, T Fiskerstrand, H Refsum, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Acta Pharmacologica Et Toxicologica|February 1, 1982
The mode of antiarrhythmic action of melperoneE S Platou, H Refsum, E S Myhre, et al.
QJM : Monthly Journal of the Association of Physicians|April 15, 2006
Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine StudyE Nurk, G S Tell, H Refsum, et al.
Biochemical Society Transactions|February 1, 1997
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteineE A Lien, G Anker, P E Lønning, et al.
Cardiovascular Research|November 1, 1990
Positive inotropy linked with class III antiarrhythmic action: electrophysiological effects of the cardiotonic agent DPI 201-106 in the dog heart in vivoE Mortensen, P M Tande, N E Kløw, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1997
Cardiovascular safety of MnDPDP and MnCl2P Jynge, H Brurok, A Asplund, et al.
Clinical Chemistry|September 11, 1998
Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapyA B Guttormsen, P M Ueland, P E Lønning, et al.
Clinical Chemistry|February 4, 1999
Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategiesG Hølleland, J Schneede, P M Ueland, et al.
European Journal of Clinical Nutrition|October 11, 2001
Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered?G T Bondevik, J Schneede, H Refsum, et al.
Circulation|May 31, 2001
Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action ProjectL El-Khairy, P M Ueland, H Refsum, et al.
International Journal of Cancer|April 22, 1993
Proliferation, migration and invasion of human glioma cells exposed to antifolate drugsA J Terzis, T Fiskerstrand, H Refsum, et al.
Pageof 28